GENE ONLINE|News &
Opinion
Blog

2022-06-30| Startups

US Bio-Entrepreneur Program Launches in the UK

by Joy Lin
Share To

Nucleate, a US-based non-profit organization dedicated to cultivating future biotech leaders, has announced its expansion into the UK, and will begin operations in London, Oxford, and Cambridge.

The venture has seen great interest among graduate scientific trainees and business students wanting to start a business in the biotech industry. Later this year, it will initiate a biotech accelerator program to educate and support aspiring students on their biotech journey. 

Related artice: Gilead Sciences Works Alongside Westminster Drug Project To Eliminate Hepatitis C 

 

Program Validation and Expansion 

 

Founded in 2019, Nucleate has validated its flagship accelerator program in 10 cities across the US, including Boston, San Francisco, New York, and Houston. Called the Activator program, it begins with grouping individual participants into teams, which will attend workshops. The teams also receive mentorships from a wide range of experts, including investors, academics and industry leaders. The efforts culminate in a final pitch showcase before a panel of judges. 

The program has birthed over 100 companies that have raised over $152 million in funding for projects such as protein sequencing (Glyphic), drug discovery (Manifold Bio), RNA synthesis (EnPlusOne) and microbial fertilizer (Ivu Biologics).

Nucleate has since stepped outside the US, launching in Switzerland and the UK, with additional incubators planned in other countries such as Israel and Japan. In the UK, the organization has plans to add additional locations beyond the existing three within a year. 

“I believe that Nucleate UK has the potential to transform the biotech entrepreneurship landscape in the United Kingdom” said Miroslav Gasparek, co-Managing Director of Nucleate UK.

The UK leadership team includes Stephanie Avraamides, Director of Operations, MPhil candidate at the University of Cambridge and Abhimanyu Gowda – Director of Strategy and BA candidate at the University of Cambridge.

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top